The 2nd JCA-AACR Precision Cancer Medicine International Conference invites you to submit your presentation to be shared at the Poster Sessions taking place between June 28-30, 2023 in Kyoto, Japan.
For instructions on how to submit your presentation, please see the submission guidelines.

Submission Guidelines

  • The abstract submission deadline is on Wednesday, April 26, 2023 (Japan Standard Time, UTC+9).
  • Those who wish to submit their abstracts are requested to complete their registration and payment prior to the deadline above.
  • The abstract submission link will be sent to you via an auto-generated receipt once your payment has been completed with a credit card.
  • The number of abstract submissions as a Lead presenter is limited to 1 (one) submission per author. However, this does not limit the number of submission as co-authors of abstracts.
  • All submissions shall be peer-reviewed.
  • The Organizing Committee reserves the right to make the final decision on all submissions.
  • Notification of submission acceptance will be made to individual authors by May 25th, 2023. (Please note the notification date has been postponed.)
  • Accepted abstracts must be presented in Kyoto by the  pre-registered author.
  • All authors (including responsible researchers) are required to submit the COI (Japanese Cancer Association/Conflict of Interest (COI) disclosure).
  • The abstracts will be published as conference proceedings on-site and in a downloadable electronic version, in exactly the same format as they were submitted.


  1. AI, computational biology
  2. Bioimaging
  3. Cancer genomic medicine
  4. Cancer model systems
  5. Cancer prevention
  6. Clinical trials
  7. Diagnostics
  8. Drug resistance
  9. Epigenetics and epigenomics
  10. Genetics and genomics
  11. Germline predisposition
  12. Immunology and immunotherapy
  13. Inflammation and cancer
  14. Liquid biopsy
  15. Microbiome
  16. Novel therapeutic targets
  17. Real-world evidence and real-world data
  18. Somatic mutations in precancerous tissue and tumor initiation
  19. Tumor microenvironment
  20. Others

COI Policy

Disclosure of Conflict of Interest

Instructions for Poster Presentation

Instructions for Poster presenters